Development of a protocol for detection of SARS-CoV-2 in sputum and endotracheal aspirates using Cepheid Xpert Xpress SARS-CoV-2
- PMID: 33490871
- PMCID: PMC7818244
- DOI: 10.1099/acmi.0.000176
Development of a protocol for detection of SARS-CoV-2 in sputum and endotracheal aspirates using Cepheid Xpert Xpress SARS-CoV-2
Abstract
Sputum and endotracheal aspirates (ETs) are not among the vendor-approved specimens for the Cepheid Xpert SARS-CoV-2 assay. However, they are the common lower respiratory tract specimens submitted for laboratory diagnosis. Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in lower respiratory tract samples is required for the discharge of patients from coronavirus disease (COVID) units at some institutions. We developed a protocol used for testing unliquified viscous sputum or tracheal aspirate with the Cepheid Xpert SARS-CoV-2 assay.
Keywords: sputum; Cepheid Xpert Xpress; SARS-CoV-2; endotracheal aspirate; rapid detection.
© 2020 The Authors.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
References
-
- Cepheid Cepheid Xpert Xpress SARS-CoV-2 Instructions for Use. April 2020(Rev C) 3260
-
- FDA Statistical guidance on reporting results from studies evaluating diagnostic tests. 2007.
LinkOut - more resources
Full Text Sources
Miscellaneous